In summary, our study revealed that HIC2 is hypermethylated in glioma and that HIC2 is an independent protective factor in glioma, suggesting that HIC2 represents a novel biomarker for the prognosis prediction of gliomas. The gene discussed is HIC2; the disease is central nervous system cancer.